FDA Blocks Approval for Libido Patch
A Food and Drug Administration advisory committee has recommended further research on Intrinsa, a skin patch to increase women's sex drives. Critics worry about breast cancer risks associated with the treatment. NPR's Joanne Silberner reports.
Comments
Discussions for this story are now closed. Please see the Community FAQ for more information.